The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 and Female Fertility: Effects, Mechanisms, Safety and Risks Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding.